MyHealthChecked PLC Directorate Change (1683H)

TIDMMHC

RNS Number : 1683H

MyHealthChecked PLC

26 July 2023

MyHealthChecked PLC

( " MyHealthChecked " or " the Company " )

Directorate Change

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that Nicholas Edwards, Chief Financial Officer will leave the business on 31 July 2023. Non-Executive Director Lesley Innes FCA, a qualified chartered accountant, will take over Board responsibility for the Company's Finance function.

Penny McCormick, Chief Executive Officer of MyHealthChecked, said: " I would like to thank Nick for the role he has played in the past 15 months at MyHealthChecked. In Lesley we have a highly skilled qualified accountant with significant PLC experience who will provide financial leadership moving forward.

"As we focus on a growth drive of our new Wellness portfolio, we will continue to review our commercial investments alongside our operational cost base to ensure that we retain a strong cash position.

"We wish Nick well in his future endeavours. "

For further information contact:

 
 MyHealthChecked PLC                                                www.myhealthchecked.com 
 Penny McCormick, Chief Executive                                           via Walbrook PR 
  Officer 
 
 SPARK Advisory Partners Limited                                   Tel: [phone] 
  (NOMAD) 
 Neil Baldwin / Jade Bayat 
 
 Dowgate Capital Limited (Broker)                                  Tel: [phone] 
 David Poutney / Nicholas Chambers 
 
 Walbrook PR Ltd (Media       Tel: [phone] or [e-mail] 
  & IR) 
 Paul McManus / Alice Woodings                               Mob: [phone] / +44 
                                                                            (0)7407 804 654 
 
 

About MyHealthChecked PLC ( https://investors.myhealthchecked.com/ )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAKZGZNVKDGFZM

(END) Dow Jones Newswires

July 26, 2023 02:00 ET (06:00 GMT)